SEATTLE, Sept. 11 Cell Therapeutics, Inc. (CTI)(Nasdaq: CTICD; and MTA: CTIC) announced today that it will host an investorday in Milan, Italy on October 3, 2008. The investor day will provide anupdate from executive management on key strategic initiatives and regulatorymilestones for the Company. The meeting will be an invitation-only event. Awebcast and live teleconference of the event will be available to allinvestors. Additional event details will provided in the near future.
About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed todeveloping an integrated portfolio of oncology products aimed at making cancermore treatable. For additional information, please visitwww.celltherapeutics.com.Media Contact: Dan Eramian T: 206.272.4343 C: 206.854.1200 E: [email protected]
www.CellTherapeutics.com/media.htm Investors Contact: Ed Bell T: 206.272.4345 Lindsey Jesch T : 206.272.4347 F : 206.272.4434 E: [email protected]
SOURCE Cell Therapeutics, Inc.